Table 5.
Characteristics of pharmacologically treated and non-pharmacologically treated adult patients with ADHD
| All patients with diagnosed ADHD
|
Newly diagnosed ADHD patients
|
|||
|---|---|---|---|---|
| Pharmacologically treated | No treatment | Pharmacologically treated | No treatment | |
| Share of total, n (%) | 34,987 (78.9) | 9,377 (21.1) | 16,365 (65.7) | 8,556 (34.3) |
| Sex, n (%) | ||||
| Male | 19,989 (78.4)a | 5,510 (21.6)a | 8,891 (64.3)b | 4,938 (35.7)b |
| Female | 14,998 (79.5)c | 3,867 (20.5)c | 7,474 (67.4)d | 3,618 (32.6)d |
| Age group, n (%) | ||||
| 18–21 years | 11,270 (77.8)e | 3,214 (22.2)e | 3,349 (63.5)f | 1,925 (36.5)f |
| 22–64 years | 23,611 (80.0)e | 5,896 (20.0)e | 12,976 (67.2)f | 6,344 (32.8)f |
| ≥65 years | 106 (28.4)e | 267 (71.6)e | 40 (12.2)f | 287 (87.8)f |
Notes:
a
Denominator is the total number of males (with or without treatment) for all patients.
b
Denominator is the total number of males (with or without treatment) for newly diagnosed patients.
c
Denominator is the total number of females (with or without treatment) for all patients.
d
Denominator is the total number of females (with or without treatment) for newly diagnosed patients.
e
Denominator is the total number in the age group (with or without treatment) for all patients.
f
Denominator is the total number in the age group (with or without treatment) for newly diagnosed patients.
Abbreviation: ADHD, attention-deficit/hyperactivity disorder.